D47.Z1
Post-transplant lymphoproliferative disorder (PTLD)
Clinical Classification Guidelines
Code First
- complications of transplanted organs and tissue (T86.-)
Medical Intelligence & Overview
Post-transplant lymphoproliferative disorder (PTLD) is a rare complication that can develop after an organ or stem cell transplant. It involves abnormal growths of lymphoid cells, which are part of the immune system. PTLD can range from benign (non-cancerous) to malignant (cancerous) conditions. It is often associated with immunosuppressive therapy used to prevent transplant rejection, which can affect the body's ability to control abnormal cell growth.
Causes & Symptoms
Clinical Causes: Immunosuppressive medications used to prevent organ rejection Infection with Epstein-Barr virus (EBV), which is linked to many cases of PTLD Other viral infections that may influence immune system regulation History of prior transplant procedures
Key Symptoms: Swelling or lumps in the neck, abdomen, or other areas Persistent fever or night sweats Unexplained weight loss Fatigue or weakness Abdominal pain or discomfort Symptoms related to organ dysfunction depending on the affected area
Diagnostic & Treatment
Diagnosis Path: Diagnosing PTLD involves multiple steps, including medical history review, physical examination, imaging tests such as CT or PET scans, and biopsy of suspected lymphoid tissue. Blood tests can also help detect EBV infection and evaluate overall immune status. In some cases, additional laboratory and molecular tests are used to confirm the presence of abnormal lymphoid proliferation and to rule out other conditions.
Treatment Protocols: Treatment strategies depend on the severity and extent of PTLD. Options may include reducing immunosuppressive therapy to rebalance immune function, antiviral treatments if EBV is involved, chemotherapy, targeted therapies, or immunotherapy. Close monitoring and collaboration among a team of specialists are essential for managing the disorder effectively. The goal is to control abnormal cell growth while preserving the function of the transplanted organ or tissue.
Clinical Advice & FAQs
Billing Guidance
Is D47.Z1 a billable ICD-10 code?
Yes, D47.Z1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D47.Z1?
Clinical documentation must specify the nature of Post-transplant lymphoproliferative disorder (PTLD) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference